These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 3044936
21. Diurnal variation of urinary "hCG beta subunit core fragment" production evaluated in patients with gynecological neoplasms. Neven P, Iles RK, Carter PG, Shepherd JH, Chard T. Clin Chem; 1994 Mar; 40(3):484-5. PubMed ID: 7510595 [No Abstract] [Full Text] [Related]
22. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers. Plebani M, Navaglia F, Basso D, De Paoli M, Nicoletto MO, Maraglino E, Torre GC. Anticancer Res; 1996 Mar; 16(6B):3833-8. PubMed ID: 9042266 [Abstract] [Full Text] [Related]
23. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature. Schutter EM, Visser JJ, van Kamp GJ, Mensdorff-Pouilly S, van Dijk W, Hilgers J, Kenemans P. Tumour Biol; 1992 Mar; 13(3):121-32. PubMed ID: 1626178 [Abstract] [Full Text] [Related]
24. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer]. Nishimura R, Kobayashi K, Katsuno M, Kobayashi T. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253 [Abstract] [Full Text] [Related]
26. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma. Patsner B, Mann WJ, Vissicchio M, Loesch M. Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774 [Abstract] [Full Text] [Related]
27. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses. Carter PG, Iles RK, Neven P, Davies AP, Shepherd JH, Chard T. Gynecol Oncol; 1993 Dec; 51(3):368-71. PubMed ID: 8112647 [Abstract] [Full Text] [Related]
28. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma. Panza N, Pacilio G, Campanella L, Peluso G, Battista C, Amoriello A, Utech W, Vacca C, Lombardi G. Cancer; 1988 Jan 01; 61(1):76-83. PubMed ID: 2446734 [Abstract] [Full Text] [Related]
31. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples. Birken S, Chen Y, Gawinowicz MA, Lustbader JW, Pollak S, Agosto G, Buck R, O'Connor J. Endocrinology; 1993 Sep 01; 133(3):1390-7. PubMed ID: 7689955 [Abstract] [Full Text] [Related]
32. Urinary gonadotropin peptide: collection of specimens and cutoff levels. Plebani M, Navaglia F, Bacelle L, Polonio S, Lazzari F, Marchetti M. J Clin Lab Anal; 1995 Sep 01; 9(4):230-3. PubMed ID: 7562239 [Abstract] [Full Text] [Related]
33. [Diagnostic significance of tumor markers for gynecologic malignancies]. Aoki D, Hirasawa A, Susumu N. Gan To Kagaku Ryoho; 2005 Mar 01; 32(3):411-6. PubMed ID: 15791829 [Abstract] [Full Text] [Related]
34. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125. Straka MB, Wagner RL, Johnson JT, Kachman KK, Eibling DE. Arch Otolaryngol Head Neck Surg; 1992 Aug 01; 118(8):802-5. PubMed ID: 1642830 [Abstract] [Full Text] [Related]
37. Purification of beta-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-beta. Blithe DL, Akar AH, Wehmann RE, Nisula BC. Endocrinology; 1988 Jan 01; 122(1):173-80. PubMed ID: 2446856 [Abstract] [Full Text] [Related]